AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
January 28, 2025 08:00 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL™ platform, announced today…